ClinicalTrials.Veeva

Menu

Genetic Risk Factors for Severe Asthma

National Institute of Allergy and Infectious Diseases (NIAID) logo

National Institute of Allergy and Infectious Diseases (NIAID)

Status

Completed

Conditions

Asthma

Study type

Observational

Funder types

NIH

Identifiers

NCT00090740
DAIT P01 AI50516

Details and patient eligibility

About

The purpose of this study is to determine whether a specific genetic factor influences the severity of asthma symptoms.

Full description

Asthma is one of the most common chronic diseases in the United States. It is well known that asthma susceptibility is inherited; however, it is unknown if asthma severity is heritable. Studies suggest that levels of interleukin-16 (IL-16) may influence asthma severity. This study will examine the role of differences in the control region of the IL-16 gene in a racially diverse group of asthmatics and nonasthmatics and will determine if the IL-16 gene control region is related to asthma severity.

Participants in this study will undergo lung function and blood tests; they will also complete a questionnaire about their respiratory health. Asthmatic participants will complete a severity-of-asthma questionnaire.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 44 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Asthmatic Participants:

  • Diagnosis of asthma

Inclusion Criteria for Non-asthmatic Participants:

  • No diagnosis of asthma

Trial design

600 participants in 2 patient groups

Asthmatics
Description:
People who have asthma
Controls
Description:
People who do not have asthma

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems